As of 4:00pm ET
| -1.51 / -0.74%|
The 19 analysts offering 12-month price forecasts for Amgen Inc have a median target of 217.00, with a high estimate of 243.00 and a low estimate of 173.00. The median estimate represents a +6.73% increase from the last price of 203.32.
The current consensus among 24 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.